Sabinsa Granted US Patent on Lactospore® for IBS

<p>Sabinsa has been granted a US patent on the company's shelf-stable probiotic Lactospore&reg;&nbsp; for its use for therapeutic management or Irritable Bowel Syndrome (IBS).</p>
Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.